2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 25.737 | 162.538 | 152.532 | 195.743 | 254.380 | 259.955 | 144.237 | 154.477 | 190.677 | 1.009.077 |
Total Income - EUR | 25.761 | 171.839 | 161.748 | 201.443 | 269.898 | 297.743 | 167.180 | 154.607 | 190.756 | 1.072.602 |
Total Expenses - EUR | 35.830 | 150.005 | 122.804 | 174.679 | 242.861 | 211.383 | 263.978 | 134.946 | 183.338 | 940.732 |
Gross Profit/Loss - EUR | -10.069 | 21.834 | 38.944 | 26.765 | 27.037 | 86.360 | -96.798 | 19.661 | 7.418 | 131.870 |
Net Profit/Loss - EUR | -10.841 | 20.246 | 37.343 | 24.409 | 24.338 | 83.370 | -98.472 | 18.110 | 5.510 | 105.200 |
Employees | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Stemisavu S.r.l.
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 110.501 | 167.345 | 164.514 | 266.141 | 260.986 | 269.861 | 187.928 | 188.511 | 188.210 | 1.159.943 |
Current Assets | 25.988 | 33.529 | 36.743 | 37.255 | 45.179 | 104.312 | 89.182 | 81.380 | 22.663 | 180.407 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 21.780 | 21.517 | 17.429 | 20.404 | 33.501 | 61.953 | 49.939 | 9.789 | 1.030 | 14.182 |
Cash | 4.208 | 12.012 | 19.315 | 16.850 | 11.678 | 42.359 | 39.243 | 71.591 | 21.634 | 166.225 |
Shareholders Funds | -10.796 | 9.560 | 46.741 | 70.292 | 93.268 | 174.870 | 72.521 | 90.856 | 96.090 | 580.509 |
Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 200 |
Debts | 147.284 | 191.315 | 154.516 | 233.103 | 212.897 | 199.302 | 204.589 | 179.035 | 114.784 | 759.841 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "4941 - 4941" | |||||||||
CAEN Financial Year |
4941
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Stemisavu S.r.l.